Supplementary Materials

The PDF file includes:

  • Fig. S1. HER2/HER3 signaling after anti-HER2 treatments and the distribution of phosphopeptides in the TMT LC-MS/MS dataset and peptide signature.
  • Fig. S2. Peptide chip array and kinase predictions.
  • Fig. S3. Counter-activation of FAK1-AKT1 signaling and the effect of combination treatments.
  • Legends for tables S1 to S3

[Download PDF]

Other Supplementary Material for this manuscript includes the following:

  • Table S1 (Microsoft Excel format). LFC of peptide abundance from TMT LC-MS/MS dataset.
  • Table S2 (Microsoft Excel format). LFC and P values for Tyr peptide phosphorylation from kinase activity profiling.
  • Table S3 (Microsoft Excel format). LFC and P values for Ser/Thr peptide phosphorylation from kinase activity profiling.